SEC Filing Details

SEC Filing Details

Document Details

Form
S-3MEF
Filing Date
Apr 2, 2018
Document Date
Apr 2, 2018
Form Description
Registration of up to an additional 20% of securities for any offering registered on a S-3
Filing Group
Registration Statements
Company
ReShape Lifesciences
Issuer
For investor inquiries, please contact:

ReShape Lifesciences Investor Contact:
Thomas Stankovich
Chief Financial Officer
949-276-6042
ir@ReShapeLifesci.com

Investor Contacts:
Rx Communications Group
Michael Miller
917-633-6086
mmiller@rxir.com

PRINT PAGE

EMAIL PAGE